Recent posts

• iosBio signs exclusive worldwide licensing agreement granting ImmunityBio rights to OraPro™ oral vaccine platform technology for COVID-19 12/01/2021
• iosBio takes next step in race for a vaccine, announces BioCell as manufacturer for OraPro-COVID-19 12/06/2020
• iosBio Biopharma earns prestigious position on WHO list of vaccine developers 11/05/2020
• iosBio Biopharma strengthens leadership team, as Jeffrey Almond joins the board in the race to develop oral vaccine for COVID-19 07/05/2020
• iosBio Biopharma joins race to develop COVID-19 vaccine delivering unique double immunity using self-administered capsules 30/04/2020
• CNBC – UK biotech developing oral COVID-19 vaccine that could be delivered in the mail 07/04/2020
• Developing a vaccine for Coronavirus – Bloomberg 31/03/2020
• iosBio’s COVID-19 Vaccine intended to be delivered in a disruptive thermally stable oral capsule 31/03/2020
• iosBio Biopharma announces cancer immunotherapy partnership with Oncolys BioPharma 23/05/2018
• iosBio wins £2m Innovate UK funding for oral Zika vaccine 06/02/2018